Diamond Pharma Services Ltd (“Diamond”), a leading technical services and regulatory affairs consulting group, providing expert support and advice to pharmaceutical and biotechnology companies, has received both the Futures and Support Award at The Organisation for Professionals in Regulatory Affairs (TOPRA) Awards. The Awards recognise the role of the Company’s expert regulatory services in supporting Kite Pharma Inc’s successful development of its CAR-T cell immunotherapy product for lymphoma and leukaemia.
Established in 2010, the TOPRA Awards recognise the achievement of individuals, teams and organisations in the regulatory affairs community. The Futures Award acknowledges the role of regulatory scientists in realising the potential of cutting-edge technologies and the Support Award recognises the critical role supporting organisations play in the drug development process and lifecycle of a drug. Diamond won both categories for its services to Kite Pharma Inc; supporting the successful development of its breakthrough CAR-T cell immunotherapy product, YESCARTA® through to Marketing Authorization Application (MAA).